274 related articles for article (PubMed ID: 11929950)
21. Estrogen replacement therapy and risk of epithelial ovarian cancer.
Risch HA
Gynecol Oncol; 1996 Nov; 63(2):254-7. PubMed ID: 8910636
[TBL] [Abstract][Full Text] [Related]
22. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
23. Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer.
Kim SJ; Rosen B; Fan I; Ivanova A; McLaughlin JR; Risch H; Narod SA; Kotsopoulos J
Br J Cancer; 2017 Mar; 116(7):964-971. PubMed ID: 28208158
[TBL] [Abstract][Full Text] [Related]
24. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Ross RK; Paganini-Hill A; Wan PC; Pike MC
J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.
Ose J; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopolou A; Benetou V; Lagiou P; Masala G; Tagliabue G; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Onland-Moret NC; Weiderpass E; Gram IT; Sánchez S; Obon-Santacana M; Sànchez-Pérez MJ; Larrañaga N; Castaño JM; Ardanaz E; Brändstedt J; Lundin E; Idahl A; Travis RC; Khaw KT; Rinaldi S; Romieu I; Merritt MA; Gunter MJ; Riboli E; Kaaks R; Fortner RT
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):951-61. PubMed ID: 25855626
[TBL] [Abstract][Full Text] [Related]
26. Alcohol consumption and ovarian cancer risk in a population-based case-control study.
Peterson NB; Trentham-Dietz A; Newcomb PA; Chen Z; Hampton JM; Willett WC; Egan KM
Int J Cancer; 2006 Nov; 119(10):2423-7. PubMed ID: 16921486
[TBL] [Abstract][Full Text] [Related]
27. Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study.
Gram IT; Lukanova A; Brill I; Braaten T; Lund E; Lundin E; Overvad K; Tjønneland A; Clavel-Chapelon F; Chabbert-Buffet N; Bamia C; Trichopoulou A; Zylis D; Masala G; Berrino F; Galasso R; Tumino R; Sacerdote C; Gavrilyuk O; Kristiansen S; Rodríguez L; Bonet C; Huerta JM; Barricarte A; Sánchez MJ; Dorronsoro M; Jirström K; Almquist M; Idahl A; Bueno-de-Mesquita HB; Braem M; Onland-Moret C; Tsilidis KK; Allen NE; Fedirko V; Riboli E; Kaaks R
Int J Cancer; 2012 May; 130(9):2204-10. PubMed ID: 21678398
[TBL] [Abstract][Full Text] [Related]
28. Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis.
Garg PP; Kerlikowske K; Subak L; Grady D
Obstet Gynecol; 1998 Sep; 92(3):472-9. PubMed ID: 9721791
[TBL] [Abstract][Full Text] [Related]
29. Does smoking increase risk of ovarian cancer? A systematic review.
Jordan SJ; Whiteman DC; Purdie DM; Green AC; Webb PM
Gynecol Oncol; 2006 Dec; 103(3):1122-9. PubMed ID: 17005245
[TBL] [Abstract][Full Text] [Related]
30. Analgesic medication use and risk of epithelial ovarian cancer in African American women.
Peres LC; Camacho F; Abbott SE; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Crankshaw S; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry P; Wang F; Schildkraut JM
Br J Cancer; 2016 Mar; 114(7):819-25. PubMed ID: 26908324
[TBL] [Abstract][Full Text] [Related]
31. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival.
Mascarenhas C; Lambe M; Bellocco R; Bergfeldt K; Riman T; Persson I; Weiderpass E
Int J Cancer; 2006 Dec; 119(12):2907-15. PubMed ID: 16998830
[TBL] [Abstract][Full Text] [Related]
32. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
33. Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.
Kim SI; Lim MC; Lim J; Won YJ; Seo SS; Kang S; Park SY
J Gynecol Oncol; 2016 Jan; 27(1):e5. PubMed ID: 26463436
[TBL] [Abstract][Full Text] [Related]
34. Menopausal hormone therapy and cancer risk: An overestimated risk?
Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
[TBL] [Abstract][Full Text] [Related]
35. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
[TBL] [Abstract][Full Text] [Related]
37. Cigarette smoking and risk of epithelial ovarian cancer.
Rossing MA; Cushing-Haugen KL; Wicklund KG; Weiss NS
Cancer Causes Control; 2008 May; 19(4):413-20. PubMed ID: 18080774
[TBL] [Abstract][Full Text] [Related]
38. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.
Wentzensen N; Poole EM; Trabert B; White E; Arslan AA; Patel AV; Setiawan VW; Visvanathan K; Weiderpass E; Adami HO; Black A; Bernstein L; Brinton LA; Buring J; Butler LM; Chamosa S; Clendenen TV; Dossus L; Fortner R; Gapstur SM; Gaudet MM; Gram IT; Hartge P; Hoffman-Bolton J; Idahl A; Jones M; Kaaks R; Kirsh V; Koh WP; Lacey JV; Lee IM; Lundin E; Merritt MA; Onland-Moret NC; Peters U; Poynter JN; Rinaldi S; Robien K; Rohan T; Sandler DP; Schairer C; Schouten LJ; Sjöholm LK; Sieri S; Swerdlow A; Tjonneland A; Travis R; Trichopoulou A; van den Brandt PA; Wilkens L; Wolk A; Yang HP; Zeleniuch-Jacquotte A; Tworoger SS
J Clin Oncol; 2016 Aug; 34(24):2888-98. PubMed ID: 27325851
[TBL] [Abstract][Full Text] [Related]
39. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
Olsson HL; Ingvar C; Bladström A
Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
[TBL] [Abstract][Full Text] [Related]
40. An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis.
Wang KC; Chang WH; Lee WL; Huang N; Huang HY; Yen MS; Guo CY; Wang PH
BMC Cancer; 2014 Nov; 14():831. PubMed ID: 25403543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
